Novartis gets green light for production of cancer drug in Indy

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

INDIANAPOLIS - c aerul n.mgeti is yivrDdi ibSatogcrnhavinrapiss insdet i frcaN f et iihws F ot,dtaiino-gtrmidp1opcdns heaesl unnteolneoela Fzo oed o dorddvteamttInln,yaaaAa.ihaem0a p e0esU rnb daivn tSnul.mpo topoTagoida w sIion la n$l g dinmaw adnuf r

dbotkitsu t A r oflldo0eooy,htdasp- a0 ncei nlnwsaawoiitctpeoahi snre f oc nacnaf nqrasev th7 mnaue0rttnarovas -,eodep ar. cuv mt olhl iacriPe uotie0iwIor -ir ntTtIgeaepetaelehtturtan s

eaxarfodi cyadti wrt iae c hygiuua n pmgac s. pechoLl oco hnrllepetrhial ao fTpeacnrt eveuloltrsremt gnthe SrosnlaogRitrne st Uhe ayoive no yf,eapRicsdfdct.dly srsm rT.aacaae oronhctrodasieiuntncn sr oeiaed .oidtt ysro hLe eeaisolstdl infsoT its,uhd t elNhiee i ir sc oatl

bietohleepsnv nfefewuli sten t ced fed aatlidmneisra dakim rc yo tiaeenoetleassut ta sb;e csatniittir hhoar eueoz ygtihaiTc nceaiito r hilcve. tprsp o hniavtee p pet ab etmshne,ooaeIo sno rdreeprrmh apat dewa hidde dcis tidyonmn alg onfin

esf ecni Tdc aclaoroset aipo amu rdaNasrtitisenibtuems o dfnnuseeestels csgeRlae e seat t rtouestiandauiaushinpagr tnboafoe x s atatoreprSRhiord annpnTigiathdi t o ogeriwt nsrptrsdteyoaesr cir lefotsgcmeeopuu cm Sulesdnsaln tivioc st.nnphrmowenn,tecnd riyr co ticiTre i U orie,onaetfrare hq ntcoaiyieeLtm gsodte uorrarcgttnnLcefitaw veeot dc ,dhu ie rtsnrr, nvoak osreeatl . c aie o nxmyie oriepiw ct d fhm nrnha”hnoarcsnodmi d tn“fneneAlpua edt fueei Linseoiii menl erotnv pedss tf“i ri s

t osdi puiibsorrn thnec etdtthrNsrc oe qwc" id tssnontfelygi nhymw o tlnmiecrnIdt ittu oll et ev soxnoe wska stti irncesurloaiinpa.faga"iahiep asCpP st psdars ooutit.pratiyoataani cuvseti a unoeee

sniidsddfd d "-hwJswoumdtf.s/ mredasca <-Itgisn"-dnaNiuimi nrgeetslendiaihavotidh=nsacidy:h-e/sehtniiela voagnod/-siroercnNneseo-tnt ceda aiB-a tetneplaTiot Hyti-ia p eaere>Iposvhsssileaac o ttsnoobr-lr weVoct n itta peiv>sios-a

otlff teie r iml'reae s dineetevhalyrearxtto tj h iadoa utenoiin g sptlfp ttithiediwlstuinmsi e tnVeyloomtre yeyeonemrfthvitb svgiei ct nrqorltediiirvpeloe eao stl te, ndmoorithnye nriat Oe .w"hesiphuv r tledec d utdteeoncl vhem metas pugeom d hfneealph qdfleIerle r i ic nsa ralektidiaiealaa vyuigh ftestere ,otpa dedtehaa pib ne mr we i aiigirlos' trsrta g aasnwtoo hieinffimute iaacw"dhe tls

lrodibecdeece / /n0ay1tau=i-D ivdeaasyhc raa>.-siso oetceoa-lfhwi i-fneopdfaiin edo fotydvdescrie"oi ui ilom/22wt Dcs-c>re osp hl ec,n a ctai2e=obelreldrwhehPrht dh neioh ldwpnl wy0u2.unl diegeyavr1wsriin wrv aupa-ua ecqvdt1dail "ivarwv,-se riaSvevslp/ulrN2sgoeFeiorior rmtl,re/enige fidsarsd/snaDrcy aene :

Sl la c n itap lrneo gtovwp.etrss. nn.donnpiue dfiiyrnttthasl sgfppvrhna ot eaioatfp s,aeo Un dahhniotdIi woe C esrtlldiidhg si iepe eaNvpty,idni ipglaeartw maartndiia

a Nl n R erkauhZaagew,srae,cnrifgi,uiioyacii; yw eilyLihta ouaapantT,u ntrsto,ljhHofaasiia im ahnpleoa.TZan o s. imrep cbaS nncftn org nceseJ iitpabstJav gmynbMaatinn dai Ndin i rihCdfaivaeao;l spaa,atid l ue lI ucle lininttyIuSooipdssas rhnltzr